Everything You Need to Know About the Windlas Biotech IPO

Windlas Biotech is launching its IPO. The public offering comprises a fresh issue of equity shares aggregating up to Rs. 165 crores and an offer for sale of 51.4 lakh equity shares from selling shareholders.

About the company:

Windlas Biotech is among the top five players in the domestic pharmaceutical formulations CDMO (Contract Development and Manufacturing Organization) industry in terms of revenue. The company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing, and commercial manufacturing of generic products. In addition to providing services and products in the CDMO market, the company also sells its products in the trade generics and OTC markets as well as export generic products to several countries.

Financial Snapshot:

Financial Year Ended Revenue (₹ Crores) PAT (₹ Crores) EPS (₹)
March 2019 311.53 63.82 37.65
March 2020 331.34 16.21 8.9
March 2021 430.70 15.57 8.7

For more information, you can refer to the IPO Prospectus filed by the company.

IPO Details:

Event Date
Issue Period 4th August 2021 to 6th August 2021
Price Range ₹ 440 to 460
Minimum Bid Quantity 165 and in multiples thereof
Finalisation of Allotment 11th August 2021
Initiation of Refunds 12th August 2021
Credit of Shares 13th August 2021
Listing Date 17th August 2021

How do I apply to the Windlas Biotech IPO?

You can apply for the Windlas Biotech IPO using any supported UPI app by following two steps:

  • Enter your bid on Console
  • Accept UPI mandate on your phone

On acceptance of the mandate, the bid amount will get blocked in your bank account. Click here to learn more.